Literature DB >> 9247478

GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D.

A Madejón1, M Fogeda, J Bartolomé, M Pardo, C González, T Cotonat, V Carreńo.   

Abstract

BACKGROUND & AIMS: No conclusive data about GB virus C (GBV-C) tropism are available. We have studied the presence of genomic and antigenomic GBV-C RNA in serum, liver, and peripheral blood cells of 56 patients with chronic hepatitis B, C, or D virus infection.
METHODS: Genomic and antigenomic GBV-C RNA were detected by reverse-transcription nested polymerase chain reaction. Specificity was confirmed by sequencing, by chemical modification of the RNA, and by using tagged primers.
RESULTS: Genomic GBV-C RNA was found in 10 of 56 (18%) of the sera. In contrast, antigenomic strand was not detected. The sequence of the amplified GBV-C RNA from 3 patients showed a 96% homology among them and from 83% to 88% with previously described isolates. Genomic GBV-C RNA was found in 7 of 7 liver samples of the patients with serum GBV-C RNA. In 6 of these 7 patients (85%), antigenomic strand was found. Genomic RNA was found in 7 of 7 of the peripheral blood cell samples of the same 7 patients. Antigenomic GBV-C RNA was not found in these cells.
CONCLUSIONS: These results suggest that GBV-C is a hepatotropic virus that replicates in the human liver. The data do not support a role for GBV-C in chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247478     DOI: 10.1053/gast.1997.v113.pm9247478

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Existence of distinct GB virus C/hepatitis G virus variants with different tropism.

Authors:  M Fogeda; J M López-Alcorocho; J Bartolomé; C Arocena; M A Martín; V Carreño
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Hepatitis viruses and non-Hodgkin's lymphoma: A review.

Authors:  Sibnarayan Datta; Soumya Chatterjee; Rudragoud S Policegoudra; Hemant K Gogoi; Lokendra Singh
Journal:  World J Virol       Date:  2012-12-12

3.  Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products.

Authors:  R Halasz; L Barkholt; C Lara; C Hultgren; Y Ando; U Broomé; B Fischler; A Nemeth; B G Ericzon; A Sönnerborg; M Sällberg
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Hepatitis G virus infection in lymphoma and in blood donors.

Authors:  J Minton; A Iqbal; A Eskiturk; W Irving; J Davies
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

5.  Hepatitis G virus infection in Amerindians and other Venezuelan high-risk groups.

Authors:  F H Pujol; Y E Khudyakov; M Devesa; M E Cong; C L Loureiro; L Blitz; F Capriles; S Beker; F Liprandi; H A Fields
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

Review 6.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

7.  In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus.

Authors:  M Fogeda; S Navas; J Martín; M Casqueiro; E Rodríguez; C Arocena; V Carreño
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  Age related prevalence of hepatitis G virus in South Africans.

Authors:  M J Mphahlele; S Aspinall; R Spooner; W F Carman
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

Review 9.  GB virus type C interactions with HIV: the role of envelope glycoproteins.

Authors:  Emma L Mohr; Jack T Stapleton
Journal:  J Viral Hepat       Date:  2009-09-15       Impact factor: 3.728

10.  Human pegivirus RNA is found in multiple blood mononuclear cells in vivo and serum-derived viral RNA-containing particles are infectious in vitro.

Authors:  Ernest T Chivero; Nirjal Bhattarai; Robert T Rydze; Mark A Winters; Mark Holodniy; Jack T Stapleton
Journal:  J Gen Virol       Date:  2014-03-25       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.